Concepedia
Statistics
Publications
90
Citations
8.2K
H-Index
43
Active since
1984
Affiliations
Norwegian Cancer Society(Current)
Oslo University Hospital
University of Oslo
Karolinska Institutet
Erasmus University Rotterdam
Steinar Aamdal is an author at Norwegian Cancer Society specializing in medicine, oncology, and cancer research.
Top concepts
MedicineOncologyCancer ResearchRadiation OncologyPharmacologyImmunologyCancer TherapyPathologyImmunotherapyPharmacotherapy
Publications per year
1984–2022
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 530 citations · Full text
Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up
Stein Sundstrøm, Roy M. Bremnes, Stein Kaasa et al. · Journal of Clinical Oncology · 2002 · 501 citations
Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study
Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 470 citations
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
Michele Maio, Jean‐Jacques Grob, Steinar Aamdal et al. · Journal of Clinical Oncology · 2015 · 469 citations · Full text
1–5 of 90